GlassScriptPhysician profile
Vikram J Arora
NPI 1255335246
$270,675.53
in general payments reported to CMS, 2019-2025
44 companies · $36K in 2025
The $36K reported for 2025 was more than what 98% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71K · 2020: $46K · 2021: $44K · 2022: $29K · 2023: $19K · 2024: $26K · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $72K · Travel and Lodging: $5,565 · Food and Beverage: $4,142 · Entertainment: $13.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $72,150.00 |
| Travel and Lodging | $5,564.53 |
| Food and Beverage | $4,142.46 |
| Entertainment | $13.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $102,013.09 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $43,562.64 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $28,967.26 | 2019-2022 | |
| Amarin Pharma, INC. | $28,882.87 | 2019-2020 | |
| Esperion Therapeutics, INC. | $22,955.52 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14,025.02 | 2025 | |
| Astellas Pharma US INC | $13,327.45 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $10,586.74 | 2019-2025 | |
| Ancora Heart, INC. | $1,755.06 | 2022 | |
| Abbott Laboratories | $1,076.82 | 2021-2025 | Mitraclip, Cardiomems, Jot Dx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $527.43 | 2019-2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $445.08 | 2021-2025 | Uptravi, Opsumit, Opsynvi |
| Medtronic USA, INC. | $312.75 | 2019-2020 | |
| Pfizer INC. | $288.41 | 2021-2025 | |
| Cvrx, INC. | $256.55 | 2019-2023 | Barostim Neo System |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $209.07 | 2019-2023 | Repatha |
| Inari Medical, INC. | $190.59 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Impulse Dynamics (USA) INC. | $169.48 | 2022-2023 | Optimizer |
| Edwards Lifesciences Corporation | $154.95 | 2025 | Sapien 3 Ultra Resilia, Pascal |
| Vertos Medical, INC. | $127.26 | 2021 | |
| Vital Connect, INC | $127.22 | 2023 | Vitalpatch Rtm |
| Sanofi-Aventis U.S. LLC | $101.46 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $97.46 | 2021-2023 | Xarelto |
| Irhythm Technologies, INC. | $70.27 | 2021-2023 | Zio Xt Patch |
| Abbvie INC. | $67.74 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $58.26 | 2021-2023 | Camzyos |
| Abiomed | $54.79 | 2023 | Impella |
| Medtronic, INC. | $41.49 | 2024-2025 | Symplicity G3, Linq II |
| Vifor Pharma, INC. | $29.06 | 2019-2021 | |
| Lantheus Medical Imaging, INC. | $21.78 | 2023 | Definity |
| Livanova USA, INC. | $19.89 | 2023 | Tandemlife |
| Lundbeck LLC | $18.46 | 2019 | |
| Boston Scientific Corporation | $17.86 | 2023 | Watchman Access System |
| Scpharmaceuticals INC. | $16.62 | 2023 | |
| Sobi, INC | $16.24 | 2021 | |
| Csl Behring | $15.72 | 2019 | |
| Akcea Therapeutics, INC. | $15.05 | 2020 | |
| Optos, INC. | $13.65 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Kiniksa Pharmaceuticals, LTD. | $13.48 | 2023 | Arcalyst |
| Novo Nordisk INC | $12.95 | 2023 | Rybelsus, Ozempic |
| Alnylam Pharmaceuticals INC. | $12.04 | 2022 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikram Arora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.